Sign inJoin waitlistJoin the waitlist

Warren Alperstein

Clinical Lead · University of Miami/Jackson Health System

Credentials: · · · · ·

History

University of Miami/Jackson Health System
Present
Pediatric Cancer · Sylvester Comprehensive Cancer Center
Present
Jackson Memorial Hospital · University of Miami/Jackson Health System
Present

University of Miami
2019–2020
Pediatric Hematology-Oncology
Jackson Memorial Hospital
2017–2018
Pediatrics
University of Chicago Medical Center
2012–2015
RUTH AND BRUCE RAPPAPORT FAC OF MED, TECHNION ISRAEL INSTITUTE OF TECHNOLOGY, HAIFA, ISRAEL
2006–2010
University of Illinois, Urbana-Champaign
2006

Research

Very Low Numbers of CD4+ FoxP3+ Tregs Expanded in Donors via TL1A-Ig and Low-Dose IL-2 Exhibit a Distinct Activation/Functional Profile and Suppress GVHD in a Preclinical Model
Biology of Blood and Marrow Transplantation · 2018 · 24 citations
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative
British Journal of Haematology · 2023 · 17 citations
Prevalence of Hypertension (HTN) and Cardiovascular Risk Factors in a Hospitalized Pediatric Hemophilia Population
Journal of Pediatric Hematology/Oncology · 2018 · First of 5 authors · 11 citations

Biljana Horn
4 papers
DC
Deepakbabu Chellapandian
4 papers
EZ
Edward Ziga
4 papers
Michael Joyce
4 papers
JF
John Fort
3 papers
MD
Mansi Dalal
3 papers · 3 as a fellow
BO
Benjamin Oshrine
2 papers
GS
Gauri Sunkersett
2 papers
John Ligon
2 papers
Jordan Milner
2 papers · 1 as a fellow
Jorge Silva
2 papers
Reema Kashif
2 papers · 2 as a fellow

Clinical trials

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2028
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2031